Profil
Reto A.
Gadient is the founder of Camino Pharma LLC, which was founded in 2014.
He is currently the Chief Scientific Officer & Head-Pharmacology at Camino Pharma LLC.
Dr. Gadient's former job was as a Biology Director at BrainCells, Inc.
Aktive Positionen von Reto A. Gadient
Unternehmen | Position | Beginn |
---|---|---|
Camino Pharma LLC
Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Gründer | 01.09.2014 |
Ehemalige bekannte Positionen von Reto A. Gadient
Unternehmen | Position | Ende |
---|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
Camino Pharma LLC
Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Health Technology |